Magic mushroom compound tested for Hard-to-Treat OCD
NCT ID NCT05370911
Summary
This study is testing whether taking two doses of psilocybin, the active compound in 'magic mushrooms,' can reduce symptoms of obsessive-compulsive disorder (OCD). It involves 30 adults with moderate-to-severe OCD who haven't gotten better with standard medications or therapy. Participants are randomly assigned to receive the treatment right away or after a waiting period, and researchers measure changes in their OCD symptoms and related psychological factors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Enact Research Collaborative (40 Temple St, 4th Floor)
New Haven, Connecticut, 06510, United States
-
Yale Program for Psychedelic Research
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.